Abstract
This study describes the design, synthesis and trypanocidal evaluation of new azaheterocyclic derivatives (4-8). These compounds were designed as megazol (1) analogs based on bioisosterism tools and were synthesized to investigate the possible pharmacophoric contribution of the 1,2,4-triazole nucleus, the position of the heterocyclic nucleus and presence of the nitro group, to the activity against the bloodstream trypomastigote forms of Trypanosoma cruzi. The most potent compound was 6, a nitro derivative obtained by substitution of a thiadiazole by a triazole ring and by moving the nitro group from C-5 position, as in 1, to the C-4 position. Finally, we have used semi-empirical theoretical calculations to discuss the correlation of some stereo electronic properties with biological activity in an attempt to understand the possible mechanism of action of the designed series of compounds.
Keywords: Azaheterocyclic derivatives, megazol, Trypanosoma cruzi, Chagas disease, chemotherapy
Medicinal Chemistry
Title: Design, Synthesis and Activity Against Trypanosoma cruzi of Azaheterocyclic Analogs of Megazol
Volume: 3 Issue: 5
Author(s): A. S. Carvalho, R. F.S. Menna-Barreto, N. C. Romeiro, S. L. de Castro and N. Boechat
Affiliation:
Keywords: Azaheterocyclic derivatives, megazol, Trypanosoma cruzi, Chagas disease, chemotherapy
Abstract: This study describes the design, synthesis and trypanocidal evaluation of new azaheterocyclic derivatives (4-8). These compounds were designed as megazol (1) analogs based on bioisosterism tools and were synthesized to investigate the possible pharmacophoric contribution of the 1,2,4-triazole nucleus, the position of the heterocyclic nucleus and presence of the nitro group, to the activity against the bloodstream trypomastigote forms of Trypanosoma cruzi. The most potent compound was 6, a nitro derivative obtained by substitution of a thiadiazole by a triazole ring and by moving the nitro group from C-5 position, as in 1, to the C-4 position. Finally, we have used semi-empirical theoretical calculations to discuss the correlation of some stereo electronic properties with biological activity in an attempt to understand the possible mechanism of action of the designed series of compounds.
Export Options
About this article
Cite this article as:
Carvalho S. A., Menna-Barreto F.S. R., Romeiro C. N., de Castro L. S. and Boechat N., Design, Synthesis and Activity Against Trypanosoma cruzi of Azaheterocyclic Analogs of Megazol, Medicinal Chemistry 2007; 3(5) . https://dx.doi.org/10.2174/157340607781745519
DOI https://dx.doi.org/10.2174/157340607781745519 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Structure-Based Drug Design and Development of Novel Synthetic Compounds
with Anti-Viral Property against SARS-COV-2
Current Drug Discovery Technologies Propranolol Safety Profile in Children
Current Drug Safety Regioselective Synthesis of Novel Fused Sulphonamide Derivatives Utilizing Microwave Irradiation
Current Microwave Chemistry Recent Developments in the Chemical Biology of Epothilones
Current Pharmaceutical Design Shared Food, Meals and Drinks: 10 Arguments Suggesting an Oral Transmission Route of SARS-CoV-2
Infectious Disorders - Drug Targets Toward the Virtual Screening of Potential Drugs in the Homology Modeled NAD+ Dependent DNA Ligase from Mycobacterium tuberculosis
Protein & Peptide Letters Agents for the Inhibition of Cholesteryl Ester Transfer Protein (CETP) and Prospects for the Future Treatment of Atherosclerosis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Baculovirus Expression Vectors for Insect and Mammalian Cells
Current Drug Targets Preparation of 2-(4-{[4-(Quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl) Propionic Acid (VUFB 20615) and 2-Methyl-2-(4-{[4-(quinolin-2- ylmethoxy)Phenyl]sulfanyl}phenyl)Propionic Acid (VUFB 20623) as Potential Antileukotrienic Agents
Current Organic Chemistry Exploring Structure-Activity Relationships of Tricyclic Farnesyltransferase Inhibitors Using ECLiPS® Libraries
Combinatorial Chemistry & High Throughput Screening Phosphorothioate-Stimulated Cellular Uptake of siRNA: A Cell Culture Model for Mechanistic Studies
Current Pharmaceutical Design Critical Clinical Evaluation of COVID-19 Patients with Tuberculosis in the Indian Sub-Continent
Current Drug Safety Identification of Potential Immunogenic Epitopes Against SARS-CoV-2 Using <i>In-Silico</i> Method: An Immunoinformatics Study
Current Proteomics The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia
Current Medicinal Chemistry New Antimicrobial Approaches: Reuse of Old Drugs
Current Drug Targets Neuroinflammation, Diabetes and COVID-19: Perspectives Coming from Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews Drug Discovery and Protein Tyrosine Phosphatases
Current Medicinal Chemistry Combretastatin A-4 Analogs as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Dual Human Carbonic Anhydrase/Cyclooxygenase-2 Inhibitors: A Promising Approach for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Detour Cum Distance Matrix Based Topological Descriptors for QSAR/QSPR Part-II: Application in Drug Discovery Process
Letters in Drug Design & Discovery